The global burden of breast cancer is rising steadily, with projections indicating a significant increase in cases and deaths by 2050. A study published in The Lancet Oncology shows that breast cancer incidence continues to climb globally, with particularly sharp increases in several low- and middle-income countries, including India.
According to the Lancet Oncology analysis, global breast cancer cases are expected to rise substantially by 2050 due to population growth, ageing, and lifestyle-related risk factors. The study projects millions of new cases annually by mid-century if current trends continue.
The researchers estimate that global breast cancer incidence could increase by more than one-third by 2050 compared to current levels. Mortality is also expected to rise, particularly in countries where early detection and treatment access remain limited.
Breast cancer remains the most commonly diagnosed cancer among women worldwide and a leading cause of cancer-related deaths.
Reporting by The Hindu highlights that India has seen nearly a 500% increase in breast cancer cases since 1990, reflecting both demographic changes and shifts in reproductive and lifestyle patterns.
India could see a 74% rise in breast cancer cases by 2050, based on projections from the Lancet study.
This places India among countries facing a rapidly expanding cancer burden, with urban regions reporting particularly high incidence rates.
Experts attribute the global and national rise in breast cancer to multiple interacting factors:
Ageing populations – Cancer risk increases with age
Delayed childbearing and fewer pregnancies
Reduced breastfeeding duration
Rising obesity and physical inactivity
Alcohol consumption
Urban lifestyle changes
Improved detection and screening have also contributed to higher reported case numbers, though mortality disparities persist between high-income and low-income regions.
If current patterns persist:
Global breast cancer cases are expected to increase significantly by 2050.
Deaths are projected to rise disproportionately in regions with limited screening and treatment infrastructure.
Low- and middle-income countries may bear the greatest increase in mortality.
The study emphasizes that without strengthened prevention, early detection, and equitable treatment access, health systems could face mounting pressure.
Breast cancer outcomes are strongly influenced by early diagnosis. Survival rates exceed 80–90% in many high-income countries when detected early, but are significantly lower in settings where diagnosis occurs at advanced stages.
Strengthening national cancer control programs, expanding screening coverage, improving awareness, and ensuring timely access to surgery, chemotherapy, radiotherapy, and targeted therapies are central to reducing future mortality.
(Rh)